Effects of a Pharmacist Intervention in the Primary Sector on Patients Medication and Health-related Quality of Life: A Randomised Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Polypharmacy Patients
- Sponsor
- Aalborg University
- Enrollment
- 400
- Locations
- 1
- Primary Endpoint
- Changes in polypharmacypatients medication
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
Brief summary: The randomised controlled trial investigates the effect of a pharmacist intervention targeting polypharmacy patient at two levels medical clinics and patient level. The purpose is to gain more knowledge to patients and physicians about their medication and to see changes in the patient's medication and health-related quality of life.
Detailed Description
The main objective of the randomised controlled trial is to investigate the clinical effects of the roll-out of the systematic offer from Nord-KAP in the North Denmark Region at two different levels (medical clinic and patient-level). The primary outcome is changes in the participant's medicine from baseline to follow up and changes in healthcare usage Secondary outcomes include investigation of cost-effectiveness and changes in patients health-related quality of life. The hypothesis is that the regional intervention delivered by the pharmacists, from Nord-KAP, can lead to a decrease in medical products compared with a control group between baseline and at 6-month follow-up. * Will the use of a pharmacists intervention lead to a decrease in the number of polypharmacy patients in medical clinics compared to a control group of medical clinics? * Will the use of a pharmacist intervention lead to an increase in the polypharmacy patients health-related quality of life compared to a control group?
Investigators
Josefine Mikkelsen
Principal Investigator
Aalborg University
Eligibility Criteria
Inclusion Criteria
- •Patients with more than 5 medicinal products prescribed besides skin remedies and antibiotic
- •Above 18 years
- •Patients in continuous medication treatment
Exclusion Criteria
- •Terminal patients
- •Patients who are not motivated to comply with the instruction of the trial
- •Do not speak/or understand written Danish
- •Patients lacking legal capacity
- •Patients living at nursing homes
Outcomes
Primary Outcomes
Changes in polypharmacypatients medication
Time Frame: 6 months
The primary outcome at patient level is changes in the patients medication use at baseline and 6-month follow-up defined as the amount of medicine prescribed. Measuring the amount of medicine is extracted by the pharmacist from the participants SMC.
Secondary Outcomes
- Healthcare services(Up to 10 years)
- Amount of medicine pr patient in each medical clinic(6 months)
- Health-related quality of life(6 months)
- Medical clinic number of polypharmacy patients(6 months)